Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.6200 (-0.53%) ($5.1000 - $5.8900) on Thu. Mar. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.37% (three month average) | RSI | 72 | Latest Price | $5.6200(-0.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 8.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) UNG(11%) BNDX(8%) TLT(8%) PCY(7%) BWX(6%) | Factors Impacting CAPR price | CAPR will decline at least -3.185% in a week (0% probabilities). XME(-21%) XRT(-20%) XHB(-19%) JNK(-19%) IVW(-19%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.185% (StdDev 6.37%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
5 Day Moving Average | $5.67(-0.88%) | 10 Day Moving Average | $5.62(0%) | 20 Day Moving Average | $5.19(8.29%) | To recent high | -17.4% | To recent low | 12.4% | Market Cap | $111m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |